Objective: Papaverine is a direct-acting vasodilating agent that is frequently used in the treatment of vasospasm after subarachnoid hemorrhage. However, not much knowledge is available about the effect of papaverine on atherosclerotic vessels. Material and Methods: Twenty-four New Zealand-type male rabbits were divided into 4 groups: normal, atherosclerotic, normal vasospastic, and atherosclerotic vasospastic vessels. The atherosclerotic groups (2 and 4) were fed with high cholesterol diet and the other groups with a normal diet for 4 weeks. Cholesterol levels were measured before and after exposure to these diets. In groups 3 and 4, a vasospasm model for common carotid arteries was established. In all subjects, papaverine was applied topically on the left common carotid artery (study subgroups a) and serum physiologic on the right (control subgroups b). Before and 10, 20, 30, 40, 50, and 60 minutes after topical application, vessel diameter was measured and compared between the groups. Histological evaluation of the artery was also performed in all subjects. Results: In the atherosclerosis groups (Groups 2 and 4), blood cholesterol levels were significantly higher after 4 weeks of high cholesterol diet. Atherosclerosis and vasospasm development were confirmed with histological examination in the respective groups. Papaverine application lead to significant dilation in all groups according to the SF application. Its most prominent vasodilating effect was seen in normal vessels, while its effect gradually decreased from groups 2 to 4. Conclusions: The vasodilating effect of papaverine decreased in the presence of atherosclerosis. New experimental and clinical studies are required to determine the effective local papaverine doses in atherosclerotic cases.
Introduction
Cerebral vasospasm was described first by Gull in 1859 (1) and was angiographically shown by Ecker and Riemenschneider in 1951 (2) . It is well known that the most frequent cause of mortality and morbidity is vasospasm in patients with spontaneous subarachnoid hemorrhage (SAH) presenting at the hospital (3) . The etiopathogenesis of vasospasm after SAH is not exactly known (4, 5) . In vivo and in vitro studies showed that oxyhemoglobin appearing with the disintegration of red blood cells induces pathological processes developing into vasospasm. In addition, it is known that some neurogenic reflex mechanisms, other disintegration products of the blood, and potassium also play a role in pathogenesis (4, 5) . Presence of a correlation between immune complexes in the blood and severity of vasospasm is shown in newer studies, and it is thought that an autoimmune process may also play a role in the development of these reactions (6) .
An exact and effective treatment modality for vasospasm
has not yet been defined because we do not know its etiopathogenesis exactly. Some treatment modalities are being tried experimentally and clinically. One of them, papaverine, is an alkaloid found at 1% in opium extract (7) . It is a very effective direct-acting vasodilator especially for arteries and arterioles (8) . It was tried intrathecally, intra-arterially, and intravenously for experimental and clinical vasospasm treatment, and it was found to be very effective (4, (9) (10) (11) .
However, its effects on atherosclerotic vessels are not known.
This study evaluated vasodilator effects of papaverine on atherosclerotic vessels with and without vasospasm in an experimental rabbit model.
Material and Methods
After approval by the local ethical committee, the study was 
Groups
In the study, 24 New Zealand-type male rabbits with a weight of 2.5-3 kg were used. They were randomly divided into 4 groups consisting of 6 rabbits each. Papaverine was topically applied on the left common carotid artery (CCA) of each subject (as "a" subgroups) and serum physiologic (SF) was given to the right CCA (as "b" subgroups). Thus, the groups were as follows: 
To Form Atherosclerosis
A rabbit model found in the literature was used to induce atherosclerosis (12, 13) . The subjects of Groups 1 and 3 were fed with normal diet and the subjects of Groups 2 and 4 were fed with a diet containing 2% cholesterol during 4 weeks.
Cholesterol levels were measured in venous blood of all subjects before and after diet.
To Induce Vasospasm
A model found in the literature was used to induce vasospasm in CCA (14) . The subjects of Groups 3 and 4 were anaesthetized with intramuscular 50 mg/kg ketamine and administration of 50 mg/kg xylazine. The subjects were kept in supine position on the table; a midline incision was performed after their anterior neck region had been shaved, and was cleaned routinely. Both CCAs were found with blunt dissection and were wrapped with small pieces of silastic sheaths. One cc arterial blood taken from the auricle artery was injected into the silastic wrapping on both sides. The layers were closed and the subjects were kept under routine cage conditions for 72 hours to await the development of vasospasm.
Measurements of Vessels
All subjects were anaesthetized with intramuscular 50 mg/kg ketamine and administration of 50 mg/kg xylazine. They were 
Pathological Evaluations
All subjects were killed by application of high-dose anesthetics intravenously, and a sample of 1 cm length of each CCA was removed and fixed in a 10% formaldehyde solution. They were dehydrated with alcohol and were bathed in paraffin. Paraffin blocks were cut at a thickness of 5 microns after freezing. After deparaffinization in xylene (3 times), they were bathed in water and stained with hematoxylin eosin dye. All slides were evaluated under a light microscope (Olympus BX7, Japan) with x100 magnification and were photographed.
Statistical Evaluation
Graphpad Instat 3.0 software was used for statistical analyses.
Nonparametric tests were preferred because of the small subject numbers in each group. To compare the papaverine and SF groups, Mann-Whitney U test was used, and to compare various parameters of all groups together, Kruskal-Wallis One Way ANOVA was used. Post-hoc evaluation was performed with Dunn's test. Changes in one group over time were compared using Wilcoxon test. P<0.05 was accepted as statistically significant for all evaluations.
Results
Cholesterol levels of all groups at the beginning and 4 weeks after diet are shown in Table 1 . In Groups 2 and 4, the cholesterol level was significantly increased after 4 weeks compared to their initial levels. However, there was no significant change in Groups 1 and 3.
Vessel diameters of all groups under initial conditions and after local papaverine/SF application are shown in Table 2 and changes are illustrated in Figure 1 .
In Group 1, increases of vessel diameters in the first 30 minutes after papaverine application were statistically highly significant compared to the initial levels (p=0.002).
Subsequently, it gradually decreased to the initial levels. In the other groups, changes in vessel diameters were generally not so prominent and decreased sooner with regard to the normal vessels. The increase in Group 4 was the lowest. In the b subgroups (SF application) of all groups, changes of vessel diameters were not significant over time in relation to the initial levels. In all groups, maximal and mean increases in vessel diameters were statistically higher in the papaverine groups compared to those in the SF groups (Table 3) .
For all groups, maximal and mean changes of vessel diameters after papaverine and SF applications are shown in Tables 4 and 5 , respectively. Maximal increase of vessel diameter was significant in Group 1 compared to Groups 3 and 4 (Table 4) , and mean increase of vessel diameter was significant in Group 1 compared to Groups 3 and 4, and in Group 2 compared to Group 4 (Table 5 ). There was no significant difference between vessel diameters between the Groups after SF application. 
Histological Findings
It was seen that the endothelial layer was thin and regular, the internal elastic lamina was thin and not undulated, and smooth muscle cells were located concentrically in the media layer in normal vessels; the thickness of the vessel walls was normal Another limitation of the use of papaverine is that it is a short-acting drug because of its quick elimination by the liver.
Therefore, topical application into the cisterna provides only a short-time activity. To get over this limitation, new studies are designed with controlled-release long-acting forms. These forms provide high local concentrations with low systemic toxicity for a long time (26, 27) , and it is thought that intracisternal application of controlled-release forms decreases the systemic side effects.
It is well known that more than half of the patients with aneurysmal SAH also suffer from atherosclerosis and These results showed that the response of atherosclerotic vessels to papaverine was weaker than the response of normal vessels, and the response of atherosclerotic/vasospastic vessels was also weaker than the response of normal vasospastic vessels. In other words, the presence of atherosclerosis decreased the vasodilator effect of papaverine, while adding vasospasm to atherosclerosis caused a greater decrease.
These results suggest that papaverine might not be effective for the treatment of vasospasm in routinely performed topical doses in the presence of atherosclerosis. Therefore, new experimental and clinical studies are required to determine the effective local papaverine doses in atherosclerotic cases.
Conflict of Interest:
The authors declared no conflict of interest.
Financial Disclosure: The authors declared no financial support.
Contribution Categories Name of Author
Development of study idea A.T., A.C.I., M.C. 
